To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab)

NCT06687928 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: CT-P6 SC
BIOLOGICAL: EU-Approved Herceptin SC

Sponsor

Celltrion